Ibopamine

This classification denotes a vasodilating agent with the molecular formula C17H25NO4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3VXW2HU8GS, chemically known as propanoic acid, 2-methyl-, 4-(2-(methylamino)ethyl)-1,2-phenylene ester but generally known as ibopamine, which bears US NIH Compound Identifier 68555. European Medicines Agency schedules Ibopamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08094MIG. The term IBOPAMINE HYDROCHLORIDE is an International Non-Proprietary Name. World Health Organization schedules ibopamine in its Anatomical Therapeutic Chemical (ATC) Classification. IBOPAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ibopamine under HS 29222900 and SITC 51462. As of Q4 2014, IBOPAMINE remains the US FDA Preferred Term for this commodity. Ibopamine bears US NLM identifiers UMLS ID C0123043 and NCI Concept Code C65875. SMILES: O(C1CC(CCNC)CCC1OC(=O)C(C)C)C(=O)C(C)C.